Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Nathan Spreng , McGill University × Clear Filters

1 results found

Cholinergic & noradrenergic contributions to presymptomatic AD progression

The development of approaches to aid early detection of the transition from healthy aging to mild cognitive impairment and Alzheimer’s disease (AD) is critically important for developing targeted strategies to halt or slow disease progression.

Project ongoing See Project & Researchers
Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Alzheimer's Association International Grant Program
Province
Québec
Start Date
2022